Find a Condition by Name
Adult Conditions
Pediatric Conditions
Health & Wellness Information
Treatment Programs
Coronavirus (COVID-19)
Find a Doctor by Name
Departments & Divisions
Locations & Maps
Forms & Medical Records
Travel & Lodging
Bill Pay
Insurance Information
Becoming a Patient
Patient Safety & Care
Health & Wellness Tips
Video Library
Infographics
Patient Education & Support
Professional Education - CME/CE
Morgridge Academy
Adult Clinical Trials
Pediatric Clinical Trials
See All Trials
Research Programs
Core Labs & Diagnostics
Tucker Medical Library
More
Tribute Gifts
Monthly Giving
Contact Development
Special Events
Legacy Gifts
Gifts of Assets
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
The primary purpose of this study is to examine the links between psychological and physical health variables in college students with cystic fibrosis (CF).
The purpose of this study is to identify risk factors that are predictive of COPD exacerbations.
Researchers are trying to determine if an investigational medication called CMK389 improves lung function for people with chronic pulmonary sarcoidosis.
Healthy individuals ages 18-25 are needed for a research study that compares perspectives on sleep among healthy young adults and cystic fibrosis patients who are on CF transmembrane regulator modulator therapy.
Can allergies be prevented in infants? Researchers want to know if keeping a baby’s skin healthy and hydrated with moisturizer will prevent the child from developing allergies such as food allergies. Learn how you and your child can help researchers.
Infants and children up to age 18 are needed for a research study to determine if following a proper skin care routine can change the characteristics of the skin. If your child has eczema, asthma or is healthy, they may be able to help researchers with this important study.
National Jewish Health researchers are studying the antibody response to COVID-19 vaccines in people with chronic conditions.
Researchers are working to understand the different ways sarcoidosis, a disease that causes scarring in the lungs, develops.
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
Researchers want to find new measures of asthma control by tracking each participant’s asthma symptoms and response to omalizumab, while collecting data with a FitBit® and smartphone.
Can frequent video calls with a pharmacist via smart phone or computer help 14-30-year-olds take their prescribed asthma medications regularly and have fewer asthma symptoms?
In the SIMPLIFY study, researchers are trying to determine whether or not it is safe for people with cystic fibrosis (CF) to stop taking either inhaled hypertonic saline or Pulmozyme® (dornase alfa) if they are also taking Trikafta™.
Are biomarkers in the blood of patients with hypersensitivity pneumonitis (HP) predictive? Researchers understand if biomarkers can help doctors understand how quickly the disease will progress
Volunteers needed to determine whether highly allergic people or people with mast cell disorders are more likely to have an allergic reaction to COVID-19 vaccines than others.
Studies have shown that weight loss can improve heart function. Researchers want to see if a ketogenic diet is an effective treatment for heart failure with preserved ejection fraction.
If you have pulmonary fibrosis, you may be able to help researchers understand if an investigational drug known as BMS-986278 can prevent or slow down pulmonary fibrosis progression.
Why do babies develop food allergies and eczema? Researchers are studying factors before birth and through age 3 that may influence the development of allergic conditions.
Researchers want to improve medical care for asthmatics with new mobile health technologies. Study participants will use at-home technologies to track and record health data and participate in surveys and questionnaires about their health.
Researchers want to know if a new blood test for patients with lung nodules may reduce the need for physicians to order lung nodule biopsies or invasive procedures.
Researchers want to know how much water is lost from the skin of pediatric patients with atopic dermatitis (eczema) before and after using the medication dupilumab.
If you currently are experiencing moderate COVID-19 symptoms, our researchers need your help to determine if an investigational drug can safely and effectively improve symptoms of mild COVID-19, and potentially shorten how long a person feels ill from the disease.
Adults with cancer who are receiving immunotherapy are needed for a new research study to understand how immunotherapy changes the body’s immune response leading to skin reactions.
Researchers want to see if a new drug, alvelestat, improves the symptoms of lung disease caused by COPD due to alpha-1 antitrypsin deficiency (AATD), as well as symptoms of AATD.
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
Our researchers want to learn more about the different types of sarcoidosis and how it develops. If you’re an adult with sarcoidosis and you are not on immunosuppressive therapy, you may be able to help.
Researchers want to know if a new medication, Saracatinib, is a more safe and effective treatment for Idiopathic Pulmonary Fibrosis (IPF) when compared to treatments that are currently available.
Adults ages 21 and older with chronic insomnia who have taken sleep medication for more than one year are needed for a clinical trial.
Researchers want to know what causes food allergies, eczema and wheezing in infants. If you’re pregnant, you may be able to help find the answer.
If you have uncontrolled asthma you may qualify for a study to help researchers understand how to treat different types of severe asthma using precision medicine.
Patients with medically inoperable stage I/IIA non-small cell lung cancer (NSCLC) who have not received prior anticancer therapy for lung cancer, may qualify for a clinical trial investigating if the combination of pembrolizumab (MK-3475) and Stereotactic Body Radiation Therapy (SBRT) may help...
If you’ve been exposed to silica dust, like stone and concrete, you may have developed a silica-related disease. National Jewish Health is creating a registry for silicosis and related diseases in order to better understand their risk factors and prevention.
National Jewish Health researchers want to understand what people with COPD know about their disease.
Our researchers are trying to determine if a study medication called omalizumab alone or combined with oral immunotherapy may help people with multiple food allergies.
Anyone with hypersensitivity pneumonitis may qualify for this observational study and help researchers find patterns for predicting ILD.
Doctors today are still learning about the causes of asthma. With just an hour of your time, you can help our researchers look deeper into the genetics of the disease and develop better treatment options
National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.
Does your mind race at night when you're trying to sleep? Our researchers are studying how people with insomnia and obstructive sleep apnea can benefit from cognitive behavioral therapy, a goal-oriented type of treatment that aims to identify and change inaccurate or negative thinking patterns...
Our researchers are working to identify the clinical, physiologic, genetic and molecular characteristics of asthmatics.
In addition to its impact on lung function and sweat chloride, a new medication regimen may improve chronic sinusitis signs and symptoms and sense of smell for people with CF.
By adding a new investigational Pulmonary Arterial Hypertension (PAH) medication to your current therapy, you could experience relaxed and widened artery walls.
By participating in our study, you can help forward research on lung disease. Our researchers are hoping to learn more about the blood cells involved in the development of scarring lung diseases and create new treatment therapies.
Already approved for advanced non-small cell lung cancer, atezolizumab is a drug that may help those with early-stage lung cancer, as well. Participants in this clinical trial may take atezolizumab in conjunction with their chemotherapy treatments.
Help us look at how specific white blood cells are associated with hypersensitivity pneumonitis (HP) and impact how your disease affects you.
The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001.
Our researchers are trying to understand the connection, as well as how to prevent and treat lung disease in RA patients.
Our researchers are trying to understand how interstitial lung disease (ILD) develops in people with rheumatoid arthritis (RA), and how it may impact their quality of life.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Our researchers are studying the lungs of current and former smokers to understand how to improve the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD), a disease that is common among smokers. You do not need to have COPD to participate in this study.
If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.
Our researchers are studying lung diseases that develop from inhaling mineral dust over time. Although the cause of diseases such as "black lung" are known, it is not well understood why some people develop these diseases and others don't.
Are you 18 or older with no history of chronic lung conditions? You may be able to help our researchers better understand lung disease. Compensation provided.
The purpose of this study is to see if a drug called sirolimus slows development of lymphangioleiomyomatosis (LAM), a lung disease in which abnormal cells growing inside the lungs prevent them from working properly.
The purpose of this clinical trial is to see if it better to receive an investigational medication or no further treatment after surgery (and possibly chemotherapy) to remove non-small cell lung cancer (NSCLC).
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.